CTCFL and chronic myelogenous leukemia, BCR-ABL1 positive: Moreover, BORIS sf1 was found to be expressed in many types of primary cancers, including retinoblastoma, chronic myelogenous leukemia, and mucoepidermoid carcinoma (Table S5).